Vor Biopharma VOR 深 滬
等待開盤 11-07 09:30:00 美东时间
19.88
+1.220
+6.54%
華盛通- 最 高20.00
- 今 開19.105
- 成交量 55.55万股
- 最 低 18.615
- 昨 收 18.66
- 總市值 12.21亿
- 52周最高 26.00
- 市盈率 靜 --
- 換手率 0.90%
- 52周最低 6.50
- 委 比 -74.88%
- 總股本 6143.43万
- 歷史最高 1272.40
- 量 比 0.83
- 振 幅 7.42%
- 歷史最低 2.622
- 每 手 1
- 風險率 4.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio granted stock options for 24,650 shares and RSUs for 5,300 shares to two new employees on November 1, 2026, under the 2023 Inducement Plan. The options have a $19.68 exercise price, vesting 25% after 12 months and monthly over 36 months. RSUs vest 25% after 12 months and quarterly over 36 months, contingent on continued employment. Both are subject to the Inducement Plan terms.
11-04 21:15
Vor Biopharma收涨3.17%，成交额1811.89万美元
11月4日，Vor Biopharma（VOR）收涨3.17%，报19.86美元，成交额1811.89万美元，市值12.2亿美元。 行情数据 • 开盘价：19...
11-04 06:38
Vor Biopharma收跌2.19%，成交额1207.67万美元
11月3日，Vor Biopharma（VOR）收跌2.19%，报19.25美元，成交额1207.67万美元，市值11.39亿美元。 行情数据 • 开盘价：1...
11-03 06:40
Vor Biopharma收涨0.38%，成交额853.05万美元
10月27日，Vor Biopharma（VOR）收涨0.38%，报18.33美元，成交额853.05万美元，市值10.84亿美元。 行情数据 • 开盘价：1...
10-27 05:44
William Blair Initiates Coverage On Vor Biopharma with Outperform Rating
William Blair analyst Myles Minter initiates coverage on Vor Biopharma (NASDAQ:VOR) with a Outperform rating.
10-21 20:38
Vor Biopharma收跌6.77%，成交额1342.98万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:46
药物受理最新动态：Vor Biopharma Inc.泰它西普注射液进口申请获受理
国家药品监督管理局药品审评中心数据显示，2026年10月12日，Vor Biopharma Inc.的泰它西普注射液申请已获受理，受理号为JXSL260027...
10-12 17:15
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio granted stock options and RSUs to 9 new employees on October 1, 2026, totaling 59,250 shares and 12,550 RSUs under the 2023 Inducement Plan. The stock options have a 10-year term with an exercise price of $18.06 per share, vesting over four years, while RSUs vest quarterly over the same period. Both are subject to continued employment and the terms of the Inducement Plan.
10-05 22:00
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio granted stock options for 83,600 shares and RSUs for 17,900 shares to 6 new employees on September 1, 2026, under the 2023 Inducement Plan. The stock options have a 10-year term with an exercise price of $22.64 per share, vesting over four years. RSUs vest similarly, with 25% after one year and the rest over the next three years. Both are subject to continued employment and the terms of the Inducement Plan. Vor Bio focuses on advancing te...
09-04 20:05
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
